Cargando…
Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era"
Crohn’s disease (CD) is characterized by transmural inflammation of the gastrointestinal tract leading to inflammatory, stricturing and/or and fistulizing disease. Once a patient develops medically refractory disease, mechanical obstruction, fistulizing disease or perforation, surgery is indicated....
Autores principales: | Lightner, Amy L., Shen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554387/ https://www.ncbi.nlm.nih.gov/pubmed/28852521 http://dx.doi.org/10.1093/gastro/gow046 |
Ejemplares similares
-
Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T‐cell immunosuppressive capacity
por: Dadgar, Neda, et al.
Publicado: (2022) -
Mesenchymal Stem Cells for Perianal Crohn’s Disease
por: Carvello, Michele, et al.
Publicado: (2019) -
Perioperative optimization of Crohn's disease
por: Lin, Chun‐Chi, et al.
Publicado: (2022) -
Vaccination in the Era of Immunosuppression
por: Alnaimat, Fatima, et al.
Publicado: (2023) -
Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era
por: Lee, Tanya, et al.
Publicado: (2020)